Weed (BUDZ) Non-Current Assets (2010 - 2026)
Weed's (BUDZ) quarterly Non-Current Assets came in at $503348.0 in Q1 2026, down 6.7% year-on-year from $539470.0 in Q1 2025, and down 1.73% quarter-over-quarter from $512201.0 in Q4 2025.
Weed (BUDZ) Non-Current Assets (2010 - 2026) Analysis & Trends
Weed's Non-Current Assets history runs 13 years deep, the most recent figure standing at $503348.0 for Q1 2026.
- On a quarterly basis, Non-Current Assets fell 6.7% year-over-year to $503348.0 in Q1 2026; TTM through Mar 2026 was $2.1 million, a 6.53% decrease from a year earlier, with the FY2025 full-year figure at $512201.0, down 6.61% from the prior year.
- Non-Current Assets eased to $503348.0 in Q1 2026 per BUDZ's latest filing, from $512201.0 in the prior quarter.
- Across five years, Non-Current Assets topped out at $1.9 million in Q1 2022 and bottomed at $503348.0 in Q1 2026.
- The 5-year median for Non-Current Assets is $575237.0 (2024), against an average of $905087.5.
- Across the five-year window, Non-Current Assets increased 22.94% in 2022 and plunged 67.12% in 2023, its largest moves.
- Year by year, Non-Current Assets stood at $1.3 million in 2022, then slumped by 54.78% to $584176.0 in 2023, then slipped by 6.11% to $548475.0 in 2024, then retreated by 6.61% to $512201.0 in 2025, then decreased by 1.73% to $503348.0 in 2026.
- Per Business Quant, the three latest BUDZ Non-Current Assets figures stand at $503348.0 (Q1 2026), $512201.0 (Q4 2025), and $521334.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 36.78 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.33 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 8.68 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 79.20 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 3.84 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.70 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 25.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.47 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 9.64 Bn |
| 10 | Weed | 3.72 Mn | 3.72 Mn | - | 503,348.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 503,348.00 |
| Dec 31, 2025 | 512,201.00 |
| Sep 30, 2025 | 521,334.00 |
| Jun 30, 2025 | 530,424.00 |
| Mar 31, 2025 | 539,470.00 |
| Dec 31, 2024 | 548,475.00 |
| Sep 30, 2024 | 557,437.00 |
| Jun 30, 2024 | 566,357.00 |
| Mar 31, 2024 | 575,237.00 |
| Dec 31, 2023 | 584,176.00 |
| Sep 30, 2023 | 591,715.00 |
| Jun 30, 2023 | 1.25 Mn |
| Mar 31, 2023 | 1.28 Mn |
| Dec 31, 2022 | 1.29 Mn |
| Sep 30, 2022 | 1.80 Mn |
| Jun 30, 2022 | 1.85 Mn |
| Mar 31, 2022 | 1.88 Mn |
| Dec 31, 2021 | 1.92 Mn |
| Sep 30, 2021 | 1.47 Mn |
| Jun 30, 2021 | 1.51 Mn |